{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04135846",
            "orgStudyIdInfo": {
                "id": "1907002490"
            },
            "organization": {
                "fullName": "Brown University",
                "class": "OTHER"
            },
            "briefTitle": "Alpha-1 Blockade for Alcohol Use Disorder (AUD)",
            "officialTitle": "A Focus on Alpha-1 Blockade as a Novel Pharmacological Treatment for AUD",
            "acronym": "DOXY",
            "therapeuticArea": [
                "Other"
            ],
            "study": "alpha-blockade-for-alcohol-use-disorder-aud"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-12-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-20",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-20",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-10-21",
            "studyFirstSubmitQcDate": "2019-10-21",
            "studyFirstPostDateStruct": {
                "date": "2019-10-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-07-07",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Carolina Haass-Koffler",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Brown University"
            },
            "leadSponsor": {
                "name": "Brown University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this research is to replicate findings previously conducted in a pilot trial and to understand, mechanistically, the role of stress in the development of AUD pharmacotherapies that target noradrenergic blockade.",
            "detailedDescription": "16 week, between-subject, double-blind, randomized clinical trial (RCT) with doxazosin (16 mg, or maximum tolerated dose, MTD) compared to placebo in 184 treatment seeking individuals with AUD"
        },
        "conditionsModule": {
            "conditions": [
                "Alcohol Use Disorder (AUD)"
            ],
            "keywords": [
                "Alcohol use disorder, stress"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 184,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "doxazosin",
                    "type": "EXPERIMENTAL",
                    "description": "16 mg, or maximum tolerated dose (MTD)",
                    "interventionNames": [
                        "Drug: Doxazosin"
                    ]
                },
                {
                    "label": "placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "matching placebo",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Doxazosin",
                    "description": "16 mg or maximum tolerated dose (MTD)",
                    "armGroupLabels": [
                        "doxazosin"
                    ],
                    "otherNames": [
                        "Cardura"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Matching placebo",
                    "armGroupLabels": [
                        "placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Alcohol consumption",
                    "description": "Number of drinks per week (DPW) in naturalistic condition as measured by the timeline follow-back (TLFB)",
                    "timeFrame": "6 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Alcohol craving",
                    "description": "We will measure alcohol craving using the Alcohol Craving Questionnaire (ACQ) after a cue-reactivity",
                    "timeFrame": "one day"
                },
                {
                    "measure": "Alcohol craving",
                    "description": "Alcohol craving in naturalistic condition will be measured using craving the Obsessive Compulsive Drinking Scale (OCDS)",
                    "timeFrame": "six weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female, 18 years of age\n* Meet the DSM-5 criteria for AUD\n* Desire to reduce or quit alcohol drinking\n* Breath alcohol (BrAC) = 0.00 at each visit\n* In good health as confirmed by medical history, physical examination and lab tests\n* Willing to adhere to the study procedures\n* Understand informed consent and questionnaires in English at an 8th grade level\n\nExclusion Criteria:\n\n* Women who are breastfeeding or /positive urine test for pregnancy\n* CrCl\\<60mL/min\n* Suicide attempt in the last three months\n* Current diagnosis of other substance disorder other than nicotine as assessed by self-report and urine toxicology screen at baseline\n* Current use of medication that may interact with doxazosin and/or yohimbine\n* History of allergy to any alpha receptor blockers\n* Clinical Institute Withdrawal Assessment for Alcohol revised (CIWA-Ar) score \u2265 8\n* Treatment with disulfiram, naltrexone, acamprosate, topiramate within 1 month prior to screening\n* Treatment with any alpha-blocker\n* Individuals with cardiac heat failure (CHF), as assessed by the medical history, the physical exam and the ECG.\n* Baseline hypotension defined as BP reading lower than 90/60 mmHg\n* Use of phosphodiesterase inhibitors (PDE5) erectile dysfunction medication",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Zoe L Brown, BA",
                    "role": "CONTACT",
                    "phone": "401-863-6646",
                    "email": "alcohol.stress.study@brown.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Carolina L Haass-Koffler, PHARMD, PHD",
                    "affiliation": "Brown University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Brown University",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "20923",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Zoe Brown",
                            "role": "CONTACT",
                            "phone": "401-863-6646"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "28551590",
                    "type": "RESULT",
                    "citation": "Haass-Koffler CL, Goodyear K, Zywiak WH, Magill M, Eltinge SE, Wallace PM, Long VM, Jayaram-Lindstrom N, Swift RM, Kenna GA, Leggio L. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug Alcohol Depend. 2017 Aug 1;177:23-28. doi: 10.1016/j.drugalcdep.2017.03.016. Epub 2017 May 16."
                },
                {
                    "pmid": "26037245",
                    "type": "RESULT",
                    "citation": "Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L. Role of the alpha1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addict Biol. 2016 Jul;21(4):904-14. doi: 10.1111/adb.12275. Epub 2015 Jun 2."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000437",
                    "term": "Alcoholism"
                },
                {
                    "id": "D000000428",
                    "term": "Alcohol Drinking"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004327",
                    "term": "Drinking Behavior"
                },
                {
                    "id": "D000019973",
                    "term": "Alcohol-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3774",
                    "name": "Alcohol Drinking",
                    "asFound": "Alcohol Use",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3783",
                    "name": "Alcoholism",
                    "asFound": "Alcohol Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7502",
                    "name": "Drinking Behavior",
                    "relevance": "LOW"
                },
                {
                    "id": "M21842",
                    "name": "Alcohol-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017292",
                    "term": "Doxazosin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000058668",
                    "term": "Adrenergic alpha-1 Receptor Antagonists"
                },
                {
                    "id": "D000000317",
                    "term": "Adrenergic alpha-Antagonists"
                },
                {
                    "id": "D000018674",
                    "term": "Adrenergic Antagonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M19586",
                    "name": "Doxazosin",
                    "asFound": "Retinoic acid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M29194",
                    "name": "Adrenergic alpha-1 Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3669",
                    "name": "Adrenergic alpha-Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20755",
                    "name": "Adrenergic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                }
            ]
        }
    },
    "hasResults": false
}